- GlobeNewswire•10 days agoMediciNova Announces FDA Granted Orphan Drug Designation to MN-166 (ibudilast) for Amyotrophic Lateral Sclerosis
LA JOLLA, Calif., Oct. 11, 2016-- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange, today announced that the U.S. Food ...
- Capital Cube•10 days ago
Categories: Yahoo Finance Get free summary analysis MediciNova, Inc. reports financial results for the quarter ended June 30, 2016. Analysis Summary numbers: Revenues of USD 0 million, Net Earnings of USD -3.20 million. The company did not record any revenues for the last twelve months making the comparison of net margin versus asset turnover meaningless. MNOV-US‘s earnings and ... Read more (Read more...)
- GlobeNewswire•26 days ago
LA JOLLA, Calif., Sept. 25, 2016-- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange, today announced that the Chicago Board ...
MediciNova Inc. (MNOV)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
|Bid||5.26 x 100|
|Day's Range||6.91 - 7.10|
|52wk Range||2.74 - 10.16|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-19.34|
|Avg Vol (3m)||50,844|
|Dividend & Yield||N/A (N/A)|